Shinya Rai

26PUBLICATIONS

172CO-AUTHORS

Rheumatology and arthritisImmunogenetics (incl. genetic immunology)Tumour immunologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (26)

Sort by Publication Date:

|Jun 09, 2026

Comparative effectiveness and safety of sarilumab vs JAK inhibitors in late- and younger-onset rheumatoid arthritis.

|Feb 02, 2026

Clonal Complexity Defines Distinct Tumor-Intrinsic Biology and Prognosis in Diffuse Large B-Cell Lymphoma.

Takahiro Haeno, Kazuko Sakai, Shuji Minamoto

|Jan 30, 2026

Multidimensional Characterization of Tumor-Immune Architecture Reveals Clinically Relevant Classic Hodgkin Lymphoma Subtypes.

Tomohiro Aoki, Gerben Duns, Shinya Rai

|Jan 04, 2026

Real-world comparative effectiveness of sarilumab versus Janus kinase inhibitors as monotherapy in rheumatoid arthritis.

Yuji Nozaki, Kazuya Kishimoto, Tetsu Itami

|Oct 28, 2025

Antipsychotic Chlorpromazine Suppresses STAT5 Signaling, Overcomes Resistance Mediated by the Gatekeeper Mutation FLT3-ITD/F691L, and Synergizes with Quizartinib in FLT3-ITD-Positive Cells.

Aki Fujii-Hanamoto, Hirokazu Tanaka, Ko Fujimoto

|Sep 24, 2025

Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma.

Franck Morschhauser, Gilles Salles, Laurie H Sehn

Pageof 5

Frequent Collaborators

J Luis Espinoza

Hirokazu Tanaka

Koji Izutsu

Kisato Nosaka

Itaru Matsumura

Yuji Nozaki

Shoko Nakayama

Koji Kato

Kazuto Nishio

Mitsuhiro Matsuda

Frequent Collaborators

J Luis Espinoza

Hirokazu Tanaka

Koji Izutsu

Kisato Nosaka